The fight against Sars-CoV-2 in 2021: What’s next?
Metagenomics applied in a rapid clinical setting was unthinkable just a few years ago but now can be deployed by any hospital with local deployment.
Shares1
With more than 1.8 million Covid-19-related deaths worldwide and more than 350,000 deaths in the United States alone, the battle against SARS-CoV-2 is raging on into 2021.
In 2020, we’ve certainly learned that better infrastructure for detection is critical in fighting diseases like Covid-19 – and metagenomics are key to better understanding and ultimately better treatment. As a consulting infectious disease physician and frontline worker, I’ve seen the battle first-hand and there is still a lot of work to do. I was lucky to get the recently after seeing patients but we are still a long way off from controlling this pandemic. However, I’ve also seen that we’re getting closer to more effectively fighting this battle and new tools are giving us the chance to better care for our patients quicker than we have ever been able to do.